CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure A Report of the American College of Cardiology Solution Set Oversight Committee Dilated cardiomyopathy: so many cardiomyopathies! Ambulatory Inotrope Infusions in Advanced Heart Failure - A Systematic Review and Meta-Analysis Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca2+-ATPase Expression in Cardiomyocytes Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors Outcomes and Effect of Treatment According to Etiology in HFrEF An Analysis of PARADIGM-HF

ConsensusVolume 74, Issue 15, October 2019

JOURNAL:J Am Coll Cardiol. Article Link

2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure A Report of the American College of Cardiology Solution Set Oversight Committee

SM Hollenberg, LW Stevenson, T Ahmad et al. Keywords: decision pathway; angiotensin receptor-neprilysin inhibitors; beta blockers; CHFcomorbidities; diuretics; guideline-directed medical therapy; heart failure

FULL TEXT PDF